Nanobiotix S.A. (NBTX)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2027-04-30 | Phase1 Readout | — |
Active Clinical Trials (2)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07224152 | NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer | PHASE2 | Recruiting | 40 |
| NCT03589339 | NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | PHASE1 | Active Not Recruiting | 145 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.